Ocuphire Pharma, Inc. engages in the research and development of ophthalmic biopharmaceutical products. It focuses on developing and commercializing therapies for the treatment of several eye disorders. The company was founded by Mina Patel Soouch and Alan R. Meyer in February 2018 and is headquartered in Farmington Hills, MI.
Saint-Louis University Hospital AP-HP, Paris, France
Robert Ballanger Hospital Aulnay-Sous-Bois, Aulnay-Sous-Bois, France
Delafontaine Hospital Saint-Denis, Saint-Denis, France
Institut de Recherche Clinique du Bénin, Abomey Calavi, Atlantique, Benin
Centre Muraz/INSP, Bobo-Dioulasso, Burkina Faso
MRC The Gambia at LSHTM, Fajara, Gambia
Savica, Jakarta, Indonesia
IPR, Bouaké, Côte D'Ivoire
IRSS, Bobo-Dioulasso, Houet, Burkina Faso
Université Jean Lorougnon Guédé de Daloa, Bonon, Côte D'Ivoire
Programme Nationale de Lutte contre la Trypanosomiase Humaine Africaine, Ministère de Santé, Division Prévention et Lutte contre la Maladie, Dubréka, Guinea
Chnear Albert Royer, Dakar, Senegal
CHU YO, Ouagadougou, Burkina Faso
Centre hospitalier Roi Baudouin, Guediawaye, Senegal
population générale (quartier Duparc (Sainte Marie) et Quartier Bois rouge), La Réunion, France
University of Health Sciences, Phnom Penh, Cambodia